Search Results - "Bestach, Y."

Acetylcholine polarizes dendritic cells toward a Th2‐promoting profile by Gori, S., Vermeulen, M., Remes‐Lenicov, F., Jancic, C., Scordo, W., Ceballos, A., Towstyka, N., Bestach, Y., Belli, C., Sabbione, F., Geffner, J., Salamone, G.

“…Background A growing body of research shows a reciprocal regulation between the neural and immune systems. Acetylcholine (ACh) is the most important…”
Get full text

Identification of driver and subclonal mutations in ASXL1 and IDH1/IDH2 genes in an Argentine series of patients with myelofibrosis by Scheps, K., Meyer, C., Bestach, Y., Enrico, A., Bengió, R., Rodríguez‐Zubieta, M., Rivas, M., De Brasi, C., Larripa, I.

Get full text

Clinical and Prognostic Features in a Series of 277 Patients with Chronic Myelomonocytic Leukemia (CMML) from South America: A Multicenter Study by Gonzalez, J.S, Bestach, Y, Arbelbide, J, Perusini, A, Romagnoli, C, Fantl, D, De Dios Soler, M, Rossenhain, M, Santos, I, Lima, W. Macedo, Velloso, E, Rocha, V, Larripa, I, Flores, M.G, Belli, C

Get full text

Acetylcholine polarizes dendritic cells toward a Th2-promoting profile by Gori, S., Vermeulen, M., Remes-Lenicov, F., Jancic, C., Scordo, W., Ceballos, A., Towstyka, N., Bestach, Y., Belli, C., Sabbione, F., Geffner, J., Salamone, G.

Get full text

P-108 Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in 470 Argentinean patients by Belli, C, Bestach, Y, Bengió, R, Sakamoto, F, Nucifora, E, Gonzalez, J, Crisp, R, Fazio, P, Pintos, N, Larripa, I

Get full text

PS1169 CYTOKINE AND ARGINASE‐1 EXPRESSION DYNAMICS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA REVEALS EARLY MOLECULAR RESPONSE TO IMATINIB by Bestach, Y., Toloza, M.J., Mattos, A. Enrico, Larripa, I., Belli, C.

“…Background: Imatinib remains as the preferred tyrosine kinase inhibitor (TKI) to treat chronic myeloid leukaemia (CML) patients. Besides its direct action…”
Get full text

246 - Clinical and Prognostic Features in a Series of 277 Patients with Chronic Myelomonocytic Leukemia (CMML) from South America: A Multicenter Study by Gonzalez, J.S., Bestach, Y., Arbelbide, J., Perusini, A., Romagnoli, C., Fantl, D., De Dios Soler, M., Rossenhain, M., Santos, I., Lima, W. Macedo, Velloso, E., Rocha, V., Larripa, I., Flores, M.G., Belli, C.

Get full text

Perfil de expresión génica de citoquinas pro-inflamatorias de pacientes con leucemia mieloide crónica en respuesta al tratamiento con imatinib by Ayllón Cabrera, I, Ferrulli, M, Belli, C, Krzywinski, A, Bestach, Y, Piaggi D Agostino, A, Larripa, I, Martorell, M

“…Imatinib represents the current first-line therapy for chronic myeloid leukaemia (CML) patients. Besides its direct action targeting BCR-ABL1, imatinib may…”
Get full text

Contribución de los polimorfismos en IFNG y TNF a las complicaciones de los pacientes sometidos a un trasplante alogénico de células progenitoras hematopoyéticas relacionado by Remaggi, G, Martínez, Jorge, Foncuberta, C, Kusminsky, G, Belli, C, Berro, M, Rivas, M.M, Vitriu, A, Bestach, Y, Padros, K, Palau, V, Larripa, I, Rodríguez, M.B, Requejo, A, Jaimovich, Gregorio

“…Complications of allogeneic hematopoietic stem cell transplantation (allo-HSCT) include variable engraftment times, acute (aGVHD) and chronic (cGVHD)…”
Get full text